New Trends in Allergy IV

Correlation Between Chronic Graft-vs-Host Disease, Mast Cell Degranulation and Fibrosis.- 23 The Regulation of Mast Cell Development, Survival and Function In Vivo by Stem Cell Factor, the Ligand for the c-kit Receptor: Clinical Implications.- 24 A Kazal-Type Inhibitor of Human Mast Cell Tryptase.- 25 Generation of Anti-inflammatory Protein in Glucocorticoid-Induced Human RM3/1 Macrophages.- 26 Granulocyte-Macrophage Colony-Stimulation Factor GM-CSF and Interleukin-5 Signal Transduction Involves Activation of LYN and SYK Protein-Tyrosine Kinases in Human Eosinophils.- 27 Bone Marrow Origin of Inflammatory Cells in Allergy.- Neuroimmunology.- 28 Tachykinins in Experimental Allergic Lung Disease.- 29 Neuropeptides in Allergy.- 30 Immunomodulatory Capacities of Alpha-Melanocyte Stimulating Hormone and Related Proopiomelanocortins.- 31 Neuropeptides, Nerve Growth Factor and Eczema.- 32 Itch and Physiological Covariates.- Atopic Eczema.- 33 Skin Barrier and Eczema.- 34 TH1 and TH2 Response in Eczema.- 35 Staphylococcus Aureus Enterotoxins Induce Histamine and Leukotriene Release in Patients with Atopic Eczema.- 36 Modulatory Factors for Tissue Eosinophilia in Atopic Eczema.- 37 Characterization of Specific T-Cell Responses to Food Antigens in Atopic Eczema (AE).- 38 Topical Ceramide Corrected Epidermal Cell Hyperproliferation and Stratum Corneum Dysmaturation.- 39 Changing of Meteorologic Factors Influences Pruritus in Atopic Eczema.- 40 Ultraviolet Therapy of Atopic Eczema.- Respiratory Allergy.- 41 Latex Type I Allergy.- 42 Molecular Characterization of a Natural Latex Extract and Serological Diagnosis of Latex Allergy.- 43 Characterization of the Alveolitis in Patients with Acute Episodes of Farmer's Lung.- 44 Release of Sulfidoleukotrienes In Vitro: A Novel Test System in the Diagnosis of Pseudo-Allergy to Acetylsalicylic Acid.- 45 The Role of Superantigenicity of Silicate in the Pathogenesis of Autoimmune Diseases in Patients with Silicosis or Asbestosis.- Critical Evaluation of Methods in Allergy Diagnosis and Therapy.- 46 Skin Prick and Intradermal Test: Critical evaluation.- 47 Nasal Provocation Test: Critical evaluation.- 48 Conjuinctival Provocation: Critical evaluation.- 49 Bronchial Provocation: Critical evaluation.- 50 Patch Tests for Contact Dermatitis: Critical evaluation.- 51 Photopatch Test: Critical evaluation.- 52 Atopy Patch Test: Critical evaluation.- 53 Predictive Testing for Allergy: Critical evaluation.- 54 In Vitro Model for Contact Sensitization: Stimulatory Capacities of Human Blood-Derived Dendritic Cells and their Phenotypical Alterations in the Presence of Contact Sensitizers.- 55 Hyposensitization: Critical evaluation.- 56 Alternatives in Allergology: Critical evaluation.- 57 "Clinical Ecology": Critical evaluation.- Therapy.- 58 Allergen Epitopes.- 59 Successful Immunotherapy with T-Cell Epitope Peptides of Bee Venom Phospholipase A2 in Two Patients with Honey Bee Venom Allergy.- 60 Onset of Action and Efficacy of Astemizole, Cetirizine, Loratadine, and Terfenadine as Tested by Controlled Antigen Challenge in an Environmental Exposure Unit.- 61 Hyposensitization with Seven Injections: A Placebo-Controlled, Double-blind Multicenter-Study of the Efficacy and Safety of a Short-term Immunotherapy With Molecular-Standardized, Unmodified Grass/Rye Allergen.- 62 Antigen Specific Peptides: Role in Immunomodulation.- 63 Self-Tolerance: Multiple Strategies for Peripheral Unresponsiveness of T Cells.